Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 18 studies | 27% ± 12% | |
oligodendrocyte precursor cell | 14 studies | 40% ± 18% | |
glutamatergic neuron | 11 studies | 48% ± 25% | |
astrocyte | 11 studies | 42% ± 17% | |
microglial cell | 10 studies | 30% ± 11% | |
oligodendrocyte | 10 studies | 36% ± 11% | |
GABAergic neuron | 9 studies | 50% ± 22% | |
macrophage | 9 studies | 32% ± 13% | |
fibroblast | 8 studies | 24% ± 5% | |
adipocyte | 6 studies | 21% ± 4% | |
neuron | 5 studies | 51% ± 18% | |
epithelial cell | 5 studies | 29% ± 13% | |
interneuron | 5 studies | 63% ± 21% | |
pericyte | 5 studies | 26% ± 16% | |
mast cell | 5 studies | 21% ± 4% | |
T cell | 5 studies | 23% ± 6% | |
endothelial cell of lymphatic vessel | 5 studies | 26% ± 3% | |
smooth muscle cell | 5 studies | 19% ± 1% | |
type I pneumocyte | 5 studies | 26% ± 8% | |
type II pneumocyte | 5 studies | 28% ± 7% | |
granule cell | 4 studies | 40% ± 10% | |
B cell | 4 studies | 27% ± 8% | |
cardiac muscle cell | 4 studies | 21% ± 2% | |
dendritic cell | 4 studies | 19% ± 3% | |
amacrine cell | 4 studies | 35% ± 14% | |
retinal cone cell | 4 studies | 25% ± 9% | |
retinal rod cell | 4 studies | 25% ± 4% | |
club cell | 4 studies | 25% ± 5% | |
progenitor cell | 3 studies | 37% ± 8% | |
GABAergic amacrine cell | 3 studies | 39% ± 12% | |
glycinergic amacrine cell | 3 studies | 39% ± 12% | |
myeloid cell | 3 studies | 25% ± 8% | |
hepatocyte | 3 studies | 33% ± 13% | |
alveolar macrophage | 3 studies | 21% ± 2% | |
ciliated cell | 3 studies | 26% ± 7% | |
monocyte | 3 studies | 25% ± 3% | |
natural killer cell | 3 studies | 23% ± 3% | |
lymphocyte | 3 studies | 33% ± 9% | |
basal cell | 3 studies | 42% ± 17% | |
mucus secreting cell | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1306.69 | 1444 / 1445 | 100% | 13.81 | 183 / 183 |
prostate | 100% | 1441.76 | 245 / 245 | 99% | 6.54 | 496 / 502 |
breast | 100% | 1596.58 | 459 / 459 | 99% | 10.64 | 1104 / 1118 |
bladder | 100% | 1490.90 | 21 / 21 | 98% | 7.54 | 496 / 504 |
thymus | 100% | 1550.38 | 652 / 653 | 99% | 7.52 | 596 / 605 |
lung | 100% | 1497.91 | 576 / 578 | 99% | 8.73 | 1139 / 1155 |
brain | 98% | 1236.37 | 2596 / 2642 | 100% | 13.74 | 705 / 705 |
ovary | 100% | 1328.52 | 180 / 180 | 97% | 6.74 | 419 / 430 |
uterus | 100% | 1521.12 | 170 / 170 | 97% | 7.96 | 447 / 459 |
stomach | 100% | 1019.86 | 359 / 359 | 97% | 8.48 | 277 / 286 |
pancreas | 99% | 855.89 | 325 / 328 | 98% | 6.03 | 174 / 178 |
intestine | 100% | 1398.40 | 966 / 966 | 96% | 6.82 | 508 / 527 |
kidney | 100% | 915.76 | 89 / 89 | 93% | 6.48 | 840 / 901 |
skin | 100% | 2857.44 | 1809 / 1809 | 93% | 9.41 | 440 / 472 |
adrenal gland | 100% | 2474.75 | 258 / 258 | 92% | 5.81 | 212 / 230 |
liver | 96% | 734.61 | 217 / 226 | 56% | 2.37 | 228 / 406 |
adipose | 100% | 1575.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.72 | 29 / 29 |
muscle | 100% | 2359.77 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1776.61 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.24 | 1 / 1 |
blood vessel | 100% | 1329.81 | 1331 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 9.55 | 43 / 45 |
heart | 90% | 604.46 | 777 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 4.53 | 64 / 80 |
peripheral blood | 56% | 1114.55 | 520 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000979 | Molecular function | RNA polymerase II core promoter sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | RFX7 |
Protein name | Regulatory factor X7 DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2) DNA-binding protein RFX7 RFX7 protein |
Synonyms | RFXDC2 |
Description | FUNCTION: Transcription factor . Acts as a transcriptional activator by binding to promoter regions of target genes, such as PDCD4, PIK3IP1, MXD4, PNRC1, and RFX5 . Plays a role in natural killer (NK) cell maintenance and immunity . May play a role in the process of ciliogenesis in the neural tube and neural tube closure (By similarity). . |
Accessions | A0A8C8UYX0 ENST00000559447.8 [Q2KHR2-3] H0YLX2 ENST00000560792.4 ENST00000559847.7 ENST00000673997.1 [Q2KHR2-1] ENST00000559447 B7ZKX1 Q2KHR2 ENST00000674082.1 [Q2KHR2-1] H0YMH6 |